Günther Deuschl Selected Research

Günther Deuschl Research Topics

Disease

85	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2002
39	Tremor (Tremors) 03/2024 - 01/2002
19	Essential Tremor (Essential Tremors) 03/2024 - 06/2007
18	Dystonia (Limb Dystonia) 10/2023 - 11/2006
13	Movement Disorders (Movement Disorder) 12/2023 - 01/2002
9	Dyskinesias (Dyskinesia) 11/2021 - 04/2002
7	Dementia (Dementias) 12/2023 - 12/2004
6	Ataxia (Dyssynergia) 01/2023 - 06/2007
5	Torticollis (Wryneck) 10/2023 - 09/2014
5	Seizures (Absence Seizure) 01/2023 - 08/2009
5	Dystonic Disorders (Writer's Cramp) 12/2017 - 12/2008
4	Cognitive Dysfunction 12/2023 - 07/2013
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2023 - 01/2020
3	Ischemic Stroke 09/2023 - 01/2007
3	Autoimmune Diseases of the Nervous System 01/2023 - 01/2017
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023 - 11/2015
3	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 08/2009
3	Pain (Aches) 01/2023 - 07/2010
3	Myoclonus (Nocturnal Myoclonus) 01/2023 - 01/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 12/2012
3	Stroke (Strokes) 01/2017 - 01/2007
3	Ischemia 11/2015 - 02/2004
3	Multiple Sclerosis 10/2015 - 06/2007
3	Camptocormia 03/2015 - 04/2010
3	Infarction (Infarctions) 03/2006 - 02/2004
2	Hallucinations (Hallucination) 12/2023 - 10/2010
2	Orthostatic Hypotension (Postural Hypotension) 09/2023 - 07/2007
2	Autonomic Nervous System Diseases (Dysautonomia) 10/2022 - 11/2010
2	Parkinsonian Disorders (Parkinsonism) 10/2022 - 12/2014
2	Multiple System Atrophy 10/2022 - 01/2010
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2019
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2007
2	Dysarthria (Spastic Dysarthria) 12/2018 - 09/2014
2	Tardive Dyskinesia 11/2018 - 01/2018
2	Blepharospasm 01/2017 - 01/2016
2	Task-Specific Focal Dystonia 01/2016 - 06/2014
2	Neurologic Manifestations (Neurological Manifestations) 10/2015 - 03/2006
2	Nausea 08/2007 - 12/2004
2	Brain Ischemia (Cerebral Ischemia) 03/2006 - 02/2004
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2006 - 05/2004
2	Inflammation (Inflammations) 05/2004 - 03/2003
1	Psychotic Disorders (Schizoaffective Disorder) 12/2023
1	Hypokinesia (Bradykinesia) 01/2023
1	Sleep Wake Disorders 01/2023
1	COVID-19 01/2023
1	Atrophy 10/2022
1	Striatonigral Degeneration 10/2022
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2022
1	Cerebellar Ataxia (Dysmetria) 10/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Epilepsy (Aura) 01/2022

Drug/Important Bio-Agent (IBA)

23	Levodopa (L Dopa)FDA LinkGeneric 03/2024 - 04/2002
7	Botulinum Toxins (Botulinum Toxin)IBA 12/2019 - 10/2010
6	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 01/2002
6	AntibodiesIBA 01/2020 - 05/2003
5	salicylhydroxamic acid (SHAM)IBA 01/2019 - 11/2006
4	AutoantibodiesIBA 01/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2002
4	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 02/2011
3	alpha-SynucleinIBA 10/2022 - 07/2015
3	Apomorphine FDA Link 01/2021 - 09/2015
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018 - 08/2015
3	Primidone (Sertan)FDA LinkGeneric 01/2018 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2011
2	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2023 - 01/2017
2	Complement System Proteins (Complement)IBA 08/2022 - 01/2022
2	SynucleinsIBA 01/2020 - 12/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 08/2009
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 01/2014
2	Immunoglobulin M (IgM)IBA 01/2019 - 05/2003
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018 - 07/2011
2	Type A Botulinum Toxins (Botox)FDA Link 01/2017 - 09/2016
2	Levetiracetam (Keppra)FDA LinkGeneric 09/2015 - 08/2012
2	Antidepressive Agents (Antidepressants)IBA 01/2014 - 01/2004
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 08/2013 - 07/2012
2	SolutionsIBA 01/2013 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2012 - 01/2010
2	Cholinergic Agents (Cholinergics)IBA 10/2010 - 12/2004
2	Anticonvulsants (Antiepileptic Drugs)IBA 08/2009 - 01/2005
2	Rituximab (Mabthera)FDA Link 08/2009 - 05/2003
2	neuromelaninIBA 07/2008 - 03/2003
2	Neuroprotective AgentsIBA 03/2006 - 05/2004
2	Antipsychotic Agents (Antipsychotics)IBA 01/2005 - 01/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2003 - 10/2002
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2023
1	anti-CASPR2 autoantibodyIBA 01/2023

Therapy/Procedure

92	Deep Brain Stimulation 03/2024 - 01/2002
36	Therapeutics 03/2024 - 04/2002
6	Electrodes (Electrode) 10/2023 - 06/2007
4	Immunotherapy 01/2023 - 08/2009
3	Injections 01/2017 - 10/2010
2	Electrocoagulation (Electrocautery) 01/2022 - 01/2022
2	Denervation 11/2021 - 01/2018
2	Aftercare (After-Treatment) 12/2018 - 09/2016
2	Microelectrodes 01/2018 - 01/2017
2	Activities of Daily Living (ADL) 01/2016 - 12/2004
2	Hyperbaric Oxygenation 03/2006 - 02/2004
1	Palliative Care (Palliative Therapy) 12/2023
1	Thrombectomy 09/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2023